Global supply chains face a wide range of low-probability, high impact risks in 2020 raising from conflict in Asia to increased emissions regulation. China’s pharmaceutical single buyer program may be key to the phase 1 trade deal with the U.S. Also: pharma harvest from phase 1 deal may be transshipments; Dollar General, Greif may bag bargains as China bans single-use plastics; new normal means same problems as Los Angeles loses out from tariffs; Macron, Trump talks might have delayed first shots in EU-U.S. trade battle; and Trump sets out the stall; Also: pharma harvest from phase 1 dea...
Copyright © 2025 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.




